AEM vs FRD

AEM's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability, while the absence of an Altman Z-Score limits distress risk assessment. Despite strong profitability metrics—ROE of 15.67%, gross margin of 70.24%, and robust earnings growth of 85.8% YoY—the stock trades at a premium valuation (P/E 31.23 vs sector avg 25.89) above both the Graham Number ($85.07) and intrinsic value estimate ($202.66). Strong recent price performance (+145% 1Y) and analyst buy recommendation are counterbalanced by weak technical trend (10/100) and limited insider sentiment (40/100). The balance between operational strength and valuation concerns leads to a neutral stance.

FRD presents a classic value-trap profile, characterized by a very weak Piotroski F-Score of 2/9 indicating deteriorating fundamental health despite explosive revenue growth of 78.6%. While the stock is objectively undervalued relative to its Graham Number ($31.6) and trades at a low P/E of 8.15, the razor-thin profit margins (2.68%) and bearish technical trend (0/100) offset the valuation appeal. The discrepancy between the high current ratio (3.59) and lower quick ratio (0.91) suggests a heavy reliance on inventory, which is risky in the cyclical steel industry. Overall, the strong top-line growth is not yet translating into fundamental financial strength.